| Objets | Détails | Catégories |
|---|---|---|
|
Relations fédérales-provinciales, Affaires étrangères, Marchés publics, Santé, Industrie, Propriété intellectuelle, Sciences et technologies
|
Advocacy as it relates to the US Administration’s Most Favored Nation drug pricing policy and its potential impact for Canada
|
Politique ou Programme
|
|
Développement économique, Santé, Sciences et technologies
|
Communicating, in general, with officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy and health of Canadians.
|
Politique ou Programme
|
|
Relations fédérales-provinciales, Santé, Recherche et développement, Sciences et technologies
|
Communicating with government officials on Bill S-243, An Act to establish a national framework for women’s health in Canada. Providing guidance, subject matter expertise and relevant information to help inform future policy development.
|
Proposition législative, Projet de loi ou résolution
|
|
Développement économique, Santé, Propriété intellectuelle, Sciences et technologies
|
Communicating with government officials on policies and/or programs that support life science research and development conducted in Canada, including manufacturing and workforce development, including measures pertaining to Canada’s Biomanufacturing and Life Sciences Strategy.
|
Politique ou Programme
|
|
Santé, Propriété intellectuelle, Commerce international, Sciences et technologies
|
Domestic and international trade policies in support of the biopharmaceutical industry, including competitive and predictable intellectual property protection, product regulation and patient access to medicines.
|
Politique ou Programme
|
Bayer Inc. ("Bayer") is a Canadian subsidiary of Bayer AG, an international research-based group with core businesses in health care, crop science, and innovative materials.Headquartered in Toronto, Ontario, Bayer Inc. operates the Bayer Group's HealthCare and MaterialScience businesses in Canada. Bayer CropScience Inc., headquartered in Calgary, Alberta operates as a separate legal entity in Canada. Together, the companies play a vital role in improving the quality of life for Canadians - producing products that fight diseases, protecting crops and animals, and developing high-performance materials for applications in numerous areas of daily life.
Viktoria Friedrich, Country President and General Manager - Pharmaceutical Division
Adresse :
2920 Matheson Blvd. East
Mississauga, ON L4W 5R6
Canada
Numéro de téléphone :
905-282-5521
Bayer Inc. ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement